Mycobacterium bovis BCG-Mediated Protection against W-Beijing Strains of Mycobacterium tuberculosis Is Diminished Concomitant with the Emergence of Regulatory T Cells

Development of new vaccines and drugs for TB: limitations and potential strategic errors

(2011) Ian M Orme   Future Microbiology

Phenotypic Definition of Effector and Memory T-Lymphocyte Subsets in Mice Chronically Infected with Mycobacterium tuberculosis

(2010) M. I. Henao-Tamayo et al.   Clinical and Vaccine Immunology

Update on Research and Development Pipeline: Tuberculosis Vaccines

(2010) Belinda Beresford et al.   CLINICAL INFECTIOUS DISEASES

Epidemiology and Challenges to the Elimination of Global Tuberculosis

(2010) Mandeep S. Jassal et al.   CLINICAL INFECTIOUS DISEASES

Pathogen-specific regulatory T cells delay the arrival of effector T cells in the lung during early tuberculosis

(2010) Shahin Shafiani et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved

(2010) Iñaki Comas et al.   NATURE GENETICS

The Population Dynamics and Control of Tuberculosis

(2010) C. Dye et al.   SCIENCE

A Defined Tuberculosis Vaccine Candidate Boosts BCG and Protects Against Multidrug-Resistant Mycobacterium tuberculosis

(2010) S. Bertholet et al.   Science Translational Medicine

The Achilles heel of BCG

(2010) Ian M. Orme   TUBERCULOSIS

IL-17 and Th17 Cells

(2009) Thomas Korn et al.   Annual Review of Immunology

Trends in tuberculosis incidence and their determinants in 134 countries

(2009) C Dye et al.   BULLETIN OF THE WORLD HEALTH ORGANIZATION

Epidemiology of antituberculosis drug resistance 2002–07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance

(2009) Abigail Wright et al.   LANCET

Clinical strains of Mycobacterium tuberculosis display a wide range of virulence in guinea pigs

(2009) Gopinath S. Palanisamy et al.   TUBERCULOSIS

Evaluation of new vaccines for tuberculosis in the guinea pig model

(2009) Ann Williams et al.   TUBERCULOSIS

Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis

(2009) Ronggai Sun et al.   VACCINE

Challenges in Estimating the Total Burden of Drug-resistant Tuberculosis

(2008) Ted Cohen et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Mycobacterium bovis BCG Immunization Induces Protective Immunity against Nine Different Mycobacterium tuberculosis Strains in Mice

(2008) B. Y. Jeon et al.   INFECTION AND IMMUNITY

Evolutionary pathway of the Beijing lineage of Mycobacterium tuberculosis based on genomic deletions and mutT genes polymorphisms

(2008) L RINDI et al.   INFECTION GENETICS AND EVOLUTION

Multidrug‐Resistant and Extensively Drug‐Resistant Tuberculosis: The National Institute of Allergy and Infectious Diseases Research Agenda and Recommendations for Priority Research

(2008) Anthony S. Fauci et al.   JOURNAL OF INFECTIOUS DISEASES

rBCG Induces Strong Antigen-Specific T Cell Responses in Rhesus Macaques in a Prime-Boost Setting with an Adenovirus 35 Tuberculosis Vaccine Vector

(2008) Isabelle Magalhaes et al.   PLoS One

Disseminated disease severity as a measure of virulence of Mycobacterium tuberculosis in the guinea pig model

(2008) Gopinath S. Palanisamy et al.   TUBERCULOSIS